Company news
Viking Therapeutics, Inc. news in 2019
Viking Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.
Viking Therapeutics Announces Initiation of Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH)
November 18, 2019
Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
November 4, 2019
Viking Therapeutics to Report Financial Results for Third Quarter 2019 on November 5, 2019
October 30, 2019
Viking Therapeutics to Present at 2019 Cantor Global Healthcare Conference
September 24, 2019
Viking Therapeutics to Report Financial Results for Second Quarter 2019 on August 1, 2019
July 24, 2019
Viking Therapeutics Appoints Kathy Rouan, Ph.D., to Board of Directors
July 1, 2019
Viking Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
May 1, 2019
Viking Therapeutics to Report Financial Results for First Quarter 2019 on May 2, 2019
April 24, 2019
Viking Therapeutics Presents New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The International Liver Congress(TM) 2019
April 10, 2019
Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The International Liver Congress(TM) 2019
April 3, 2019